Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Construction in Progress (2023 - 2024)

Historic Construction in Progress for HCW Biologics (HCWB) over the last 2 years, with Q4 2024 value amounting to $13.5 million.

  • HCW Biologics' Construction in Progress rose 2980.77% to $13.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $13.5 million, marking a year-over-year increase of 2980.77%. This contributed to the annual value of $13.5 million for FY2024, which is 2980.77% up from last year.
  • Per HCW Biologics' latest filing, its Construction in Progress stood at $13.5 million for Q4 2024, which was up 2980.77% from $10.4 million recorded in Q4 2023.
  • HCW Biologics' Construction in Progress' 5-year high stood at $13.5 million during Q4 2024, with a 5-year trough of $10.4 million in Q4 2023.